Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $1.6 million.

  • Gossamer Bio's Amortizatization of Intangibles fell 5667.03% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 2801.2%. This contributed to the annual value of $13.1 million for FY2024, which is 3822.22% up from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Amortizatization of Intangibles is $1.6 million, which was down 5667.03% from $1.9 million recorded in Q2 2025.
  • Gossamer Bio's 5-year Amortizatization of Intangibles high stood at $3.7 million for Q3 2024, and its period low was $639000.0 during Q2 2022.
  • For the 4-year period, Gossamer Bio's Amortizatization of Intangibles averaged around $2.1 million, with its median value being $1.9 million (2025).
  • As far as peak fluctuations go, Gossamer Bio's Amortizatization of Intangibles skyrocketed by 44027.15% in 2023, and later plummeted by 5667.03% in 2025.
  • Over the past 4 years, Gossamer Bio's Amortizatization of Intangibles (Quarter) stood at $663000.0 in 2022, then skyrocketed by 440.27% to $3.6 million in 2023, then dropped by 6.09% to $3.4 million in 2024, then plummeted by 52.88% to $1.6 million in 2025.
  • Its Amortizatization of Intangibles stands at $1.6 million for Q3 2025, versus $1.9 million for Q2 2025 and $2.7 million for Q1 2025.